Document is current
Any future updates will be listed below
-
Authors
Hasenauer, Natalie https://orcid.org/0009-0000-4681-5457
Müller, Miriam
Hänscheid, Heribert
Serfling, Sebastian E.
Michalski, Kerstin
Heinrich, Marieke
Polat, Bülent
Buck, Andreas K.
Werner, Rudolf A.
Hartrampf, Philipp E.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 8 May 2025
First Online: 2 June 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki. Ethical review and approval were waived for this study by the local Ethics Committee due to the retrospective character of the study (waiver number 2022072501).
: Informed consent was obtained from all subjects involved in the study.
: A.K.B. and K.M. have received speaker honoraria from Novartis. R.A.W. has received speaker honoraria from Novartis and PentixaPharm and reports advisory board work for Novartis/AAA and Bayer. All other authors declare no conflict of interest.
